BCSF: the cash flow

Cash Flow Overview

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2026-06-30

2026-03-31

2025-12-31

2025-09-30

Net increase in net assets resulting from operations

14,055

3,390

27,784

70,972

Purchases of investments

172,057

234,383

157,958

1,150,381

Proceeds from principal payments and sales of investments

243,124

245,867

192,969

1,052,024

Net realized (gain) loss from investments

-13,903

-9,628

1,311

-29,539

Net realized (gain) loss on foreign currency transactions

-889

667

Net change in unrealized appreciation on forward currency exchange contracts

3,214

6,546

1,558

-482

Net change in unrealized appreciation on investments

391

-17,834

-3,587

25,162

Net change in unrealized appreciation on foreign currency translation

-227

-135

-301

1,736

Increase in investments due to pik

12,054

7,385

10,530

23,351

Accretion of discounts and amortization of premiums

-88

-1,746

-1,366

-3,788

Amortization of deferred financing costs and debt issuance costs

1,471

1,538

1,359

3,844

Collateral on derivatives

1,207

-1,180

-117

1,355

Interest receivable on investments

-1,209

-2,932

782

-1,923

Interest rate swap

-25

-108

-112

Prepaid insurance

-185

-212

-238

530

Dividend receivable

-381

-434

1,297

-1,688

Interest payable

-2,313

-1,466

-569

-915

Collateral payable on derivatives

-4,760

-8,147

4,597

8,310

Base management fee payable

-93

-323

-22

270

Incentive fee payable

-4,817

-259

1,278

-97

Accounts payable and accrued expenses

-3,639

3,915

-29,634

27,773

Net cash provided by (used in) operating activities

70,786

26,636

27,151

8,996

Borrowings on debt

84,000

643,000

141,385

405,615

Repayments on debt

30,000

649,000

167,000

472,500

Payments of financing costs

8,314

785

Proceeds from issuances of common stock (net of offering and underwriting costs)

Purchase of common shares issued in connection with dividend reinvestment plan

Stockholder distributions paid

27,245

36,975

29,191

Net cash provided by (used in) financing activities

26,753

-51,289

-54,806

-96,861

Net increase in cash, foreign cash, restricted cash and cash equivalents

97,539

-24,653

-27,655

-87,865

Effect of foreign currency exchange rates

-1,116

-69

-207

2,403

Cash, foreign cash, restricted cash and cash equivalents, beginning of period

34,188

58,910

86,772

99,066

Cash, foreign cash, restricted cash and cash equivalents, end of period

130,611

Cash interest paid during the period

41,686

Cash paid for excise taxes during the period

3,363

Cash

97,187

Restricted cash

18,467

Foreign cash

14,957

Total cash, foreign cash, restricted cash, and cash equivalents shown in the consolidated statements of cash flows

130,611

34,188

58,910

86,772

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow Overview

Unit: Thousand (K) dollars

Positive Cash Flow Breakdown

Negative Cash Flow Breakdown

Cash Flow

2026-06-30

2026-03-31

2025-12-31

2025-09-30

Net increase in net assets resulting from operations

14,055

3,390

27,784

70,972

Purchases of investments

172,057

234,383

157,958

1,150,381

Proceeds from principal payments and sales of investments

243,124

245,867

192,969

1,052,024

Net realized (gain) loss from investments

-13,903

-9,628

1,311

-29,539

Net realized (gain) loss on foreign currency transactions

-889

667

Net change in unrealized appreciation on forward currency exchange contracts

3,214

6,546

1,558

-482

Net change in unrealized appreciation on investments

391

-17,834

-3,587

25,162

Net change in unrealized appreciation on foreign currency translation

-227

-135

-301

1,736

Increase in investments due to pik

12,054

7,385

10,530

23,351

Accretion of discounts and amortization of premiums

-88

-1,746

-1,366

-3,788

Amortization of deferred financing costs and debt issuance costs

1,471

1,538

1,359

3,844

Collateral on derivatives

1,207

-1,180

-117

1,355

Interest receivable on investments

-1,209

-2,932

782

-1,923

Interest rate swap

-25

-108

-112

Prepaid insurance

-185

-212

-238

530

Dividend receivable

-381

-434

1,297

-1,688

Interest payable

-2,313

-1,466

-569

-915

Collateral payable on derivatives

-4,760

-8,147

4,597

8,310

Base management fee payable

-93

-323

-22

270

Incentive fee payable

-4,817

-259

1,278

-97

Accounts payable and accrued expenses

-3,639

3,915

-29,634

27,773

Net cash provided by (used in) operating activities

70,786

26,636

27,151

8,996

Borrowings on debt

84,000

643,000

141,385

405,615

Repayments on debt

30,000

649,000

167,000

472,500

Payments of financing costs

8,314

785

Proceeds from issuances of common stock (net of offering and underwriting costs)

Purchase of common shares issued in connection with dividend reinvestment plan

Stockholder distributions paid

27,245

36,975

29,191

Net cash provided by (used in) financing activities

26,753

-51,289

-54,806

-96,861

Net increase in cash, foreign cash, restricted cash and cash equivalents

97,539

-24,653

-27,655

-87,865

Effect of foreign currency exchange rates

-1,116

-69

-207

2,403

Cash, foreign cash, restricted cash and cash equivalents, beginning of period

34,188

58,910

86,772

99,066

Cash, foreign cash, restricted cash and cash equivalents, end of period

130,611

Cash interest paid during the period

41,686

Cash paid for excise taxes during the period

3,363

Cash

97,187

Restricted cash

18,467

Foreign cash

14,957

Total cash, foreign cash, restricted cash, and cash equivalents shown in the consolidated statements of cash flows

130,611

34,188

58,910

86,772

Time Plot

Show the time plot by selecting a row from the table.